UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000001780
Receipt No. R000002146
Scientific Title Phase I/II study of intermittent erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer
Date of disclosure of the study information 2009/03/17
Last modified on 2019/07/17 16:08:55

No. Disposal Last modified on Item of update
1 Insert 2009/03/17 18:13:01
2 Update 2009/05/19 16:26:50 Recruitment status
3 Update 2009/12/21 17:02:28 Recruitment status
4 Update 2010/03/17 09:15:23 Last follow-up date
5 Update 2010/09/17 09:31:35 Name of person sending information
6 Update 2011/06/01 11:36:22 Primary outcomes
Key secondary outcomes
Key secondary outcomes
7 Update 2011/06/01 16:20:09 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
8 Update 2015/02/21 12:34:54 Recruitment status
Last follow-up date
9 Update 2019/01/29 18:06:09 Recruitment status
Publication of results
10 Update 2019/07/17 16:07:42 Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
11 Update 2019/07/17 16:08:55 Recruitment status
Date of IRB
Last follow-up date


Contact us.